Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families
โ Scribed by Ford, D. (author);Easton, D. F. (author);Stratton, M. (author);Narod, S. (author);Goldgar, D. (author);Devilee, P. (author);Bishop, D. T. (author);Weber, B. (author);Lenoir, G. (author);Chang-Claude, J. (author);Sobol, H. (author);Teare, M. D. (author);Struewing, J. (author);Arason, A. (author);Scherneck, S. (author);Peto, J. (author);Rebbeck, T. R. (author);Tonin, P. (author);Neuhausen, S. (author);Barkardottir, R. (author);Eyfjord, J. (author);Lynch, H. (author);Ponder, B. A.J. (author);Gayther, S. A. (author);Birch, J. M. (author);Lindblom, A. (author);Stoppa-Lyonnet, D. (author);Bignon, Y. (author);Borg, A. (author);Hamann, U. (author);Haites, N. (author);Scott, R. J. (author);Maugard, C. M. (author);Vasen, H. (author);Seitz, S. (author);Cannon-Albright, L. A. (author);Schofield, A. (author);Zelada-Hedman, M. (author)
- Book ID
- 117852320
- Publisher
- Cell Press
- Year
- 1998
- Tongue
- English
- Weight
- 141 KB
- Volume
- 62
- Category
- Article
- ISSN
- 0002-9297
- DOI
- 10.1086/301749
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
We have screened index cases from 25 Russian breast/ovarian cancer families for germ-line mutations in all coding exons of the BRCA1 and BRCA2 genes, using multiplex heteroduplex analysis. In addition we tested 22 patients with breast cancer diagnosed before age 40 without family history and 6 patie
The two major hereditary breast/ovarian cancer predisposition tumor suppressor genes, BRCA1 and BRCA2 that perform apparently generic cellular functions nonetheless cause tissue-specific syndromes in the human population when they are altered, or mutated in the germline. However, little is known abo
A series of 45 high-risk breast cancer patients, consisting of 25 affected individuals from 16 families in China with at least two cases of breast cancer and 20 cases of breast cancer diagnosed under age 35 without reported family history, were studied for germline mutations of the BRCA1 and BRCA2 g